I'm sure that the DCVax-L will not be that hard on pets, but remember to get there they have to have surgery, then they'll need other forms of chemo, in addition to the DCVax-L for it to be most effective. I just don't believe that either the cost or pain is justified.
I have a 10 year old golden labradoodle who has a couple of fatty cysts, one the size of a baseball. The vet tells me they're not hurting the dog, but they can be surgically removed if I wish to pay for it. I asked if it doesn't just put the dog through more pain and his answer was yes, I see no reason to put him through that so I feel better looking at him. If they were cancerous and giving him pain I'm really not sure if I'd treat him, or have him put to sleep especially given the fact that he probably only has a couple years to live anyway. I've known people who spent a small fortune on an 16 year old dog, we love them, but there is a time the dog shouldn't be put through so much pain in order to keep him alive, he did die a matter of months later.
Today the biotech's in general were down, at one board investors believe the shorts were out big time after AACR, I don't know how true this was, but clearly we were an exception to the general biotech market. I continue to believe that we'll be a very different company by the time we reach the Annual Meeting, whenever they call it for, and I think we'll be a substantial multiple of todays prices. Meanwhile, we should continue to rise and approach prior 12 month highs before the real news is out. How high we go after we finally learn what's happened in the trial, and what the company has been doing in over a year and a half since they declared the quiet period will determine how much we can sustains after we get the news. It's very possible that if we get the right media coverage we could go substantially higher than rightfully should be sustained, it certainly could be a trading situation even for a long term holder like me.
Gary
